SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-132619
Filing Date
2017-04-21
Accepted
2017-04-21 16:31:07
Documents
4
Period of Report
2017-05-31
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d256733ddef14a.htm DEF 14A 1042832
2 GRAPHIC g256733001n.jpg GRAPHIC 165889
3 GRAPHIC g2567332n.jpg GRAPHIC 137368
4 GRAPHIC g256733g38b79.jpg GRAPHIC 84243
  Complete submission text file 0001193125-17-132619.txt   1577150
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 17776265
SIC: 2834 Pharmaceutical Preparations